Phase II Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

This study has been completed.
Sponsor:
Collaborator:
The Leukemia and Lymphoma Society
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00186628
First received: September 14, 2005
Last updated: March 11, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
No publications provided by Stanford University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):